Volume | 6,444 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Nutriband Inc | NTRBW | NASDAQ | Equity Warrant |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.58 | 1.58 | 1.85 | 1.85 | 1.59 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
---|---|---|---|---|
29 | 6,444 | 1.84 | 11,875 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 1 | 1.60 | USD |
Nutriband Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
12.45M | 7.83M | - | 2.09M | -5.49M | -0.70 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Nutriband
Date | Time | Source | Heading |
---|---|---|---|
2/13/2025 | 10:59 | Edgar (US Regulatory) | Form 8-K - Current report |
2/13/2025 | 06:00 | GlobeNewswire Inc. | Nutriband and Kindeva Drug Delivery Formalize Exclusive.. |
2/12/2025 | 15:12 | Edgar (US Regulatory) | Form 8-K - Current report |
2/11/2025 | 08:00 | GlobeNewswire Inc. | Nutriband Inc. Announces Olympian Anastasia Nichita to.. |
2/07/2025 | 07:45 | GlobeNewswire Inc. | Nutriband Receives Notice Of Allowance For New U.S. Patent.. |
1/29/2025 | 16:22 | Edgar (US Regulatory) | Form 8-K - Current report |
12/31/2024 | 06:00 | GlobeNewswire Inc. | Nutriband Issues Letter to Shareholders |
12/30/2024 | 14:59 | Edgar (US Regulatory) | Form 8-K - Current report |
12/27/2024 | 08:25 | GlobeNewswire Inc. | Nutriband Extends Chinese Patent to Macao for its AVERSA™.. |
12/16/2024 | 10:35 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
12/04/2024 | 08:00 | GlobeNewswire Inc. | Nutriband Inc. Quarterly Report Highlights Record Revenue.. |
12/04/2024 | 06:00 | GlobeNewswire Inc. | Nutriband Inc. to Present at The 2024 Noble Conference in.. |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
NTRBW Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products. |